AAOS 2016: TXA improves clinical and surgical outcomes after foot and ankle surgery .
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2016;4(5):25100 patients undergoing foot and ankle surgery were randomized to either administration of tranexamic acid (TXA), or a control group without TXA administration. The purpose of this study was to determine whether the use of TXA was associated with reductions in perioperative morbidity in foot and ankle procedures. Findings indicated significantly decreased ecchymosis, edema, erythema, and bleeding in patients who received TXA compared to individuals who did not. Pain, swelling, and blood loss was also significantly reduced in the TXA group after 2 and 6 postoperative weeks.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!
0 of 4 monthly FREE articles unlocked
